ANTI-PARKINSONISM DRUG THERAPY.

Suppr

超能文献

作者信息

FRIEND D G

出版信息

Clin Pharmacol Ther. 1963 Nov-Dec;4:815-22. doi: 10.1002/cpt196346815.

DOI:10.1002/cpt196346815

PMID:14079254

Abstract

摘要

相似文献

ANTI-PARKINSONISM DRUG THERAPY.

Clin Pharmacol Ther. 1963 Nov-Dec;4:815-22. doi: 10.1002/cpt196346815.

THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.

Bull Johns Hopkins Hosp. 1964 Dec;115:465-80.

PARKINSONISM: AETIOLOGY AND TREATMENT.

Lond Clin Med J. 1964 Jan;5:41-9.

PARKINSON'S DISEASE.

Physiotherapy. 1963 Dec 10;49:378-80.

Antiparkinsonism drugs.

Med Lett Drugs Ther. 1965 Mar 12;7(6):22-4.

A COMPARATIVE STUDY OF TRIHEXYPHENIDYL (ARTANE) AND ORPHENADRINE (DISIPAL) IN THE TREATMENT OF GERIATRIC PARKINSONISM.

J Am Geriatr Soc. 1965 Aug;13:756-9. doi: 10.1111/j.1532-5415.1965.tb00632.x.

ORPHENADRINE IN THE TREATMENT OF PARKINSON'S DISEASE.

Curr Med Drugs. 1964 Sep;5(1):24-31.

THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS.

Int J Neuropharmacol. 1965 Jul;4:207-18. doi: 10.1016/0028-3908(65)90037-7.

TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.

Psychopharmacologia. 1964 Mar 11;5:301-5. doi: 10.1007/BF02341262.

Assessment of drug therapy in Parkinsonism.

Br Med J. 1963 Feb 16;1(5328):443-8. doi: 10.1136/bmj.1.5328.443.

引用本文的文献

The management of neuroleptic-induced CNS effects.

Can Fam Physician. 1981 Oct;27:1615-24.

Intestinal obstruction complicating orphenadrine treatment.

Br Med J. 1976 Jan 3;1(6000):21-2. doi: 10.1136/bmj.1.6000.21-a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

ANTI-PARKINSONISM DRUG THERAPY.

Clin Pharmacol Ther. 1963 Nov-Dec;4:815-22. doi: 10.1002/cpt196346815.

THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.

Bull Johns Hopkins Hosp. 1964 Dec;115:465-80.

PARKINSONISM: AETIOLOGY AND TREATMENT.

Lond Clin Med J. 1964 Jan;5:41-9.

PARKINSON'S DISEASE.

Physiotherapy. 1963 Dec 10;49:378-80.

Antiparkinsonism drugs.

Med Lett Drugs Ther. 1965 Mar 12;7(6):22-4.

A COMPARATIVE STUDY OF TRIHEXYPHENIDYL (ARTANE) AND ORPHENADRINE (DISIPAL) IN THE TREATMENT OF GERIATRIC PARKINSONISM.

J Am Geriatr Soc. 1965 Aug;13:756-9. doi: 10.1111/j.1532-5415.1965.tb00632.x.

ORPHENADRINE IN THE TREATMENT OF PARKINSON'S DISEASE.

Curr Med Drugs. 1964 Sep;5(1):24-31.

THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS.

Int J Neuropharmacol. 1965 Jul;4:207-18. doi: 10.1016/0028-3908(65)90037-7.

TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.

Psychopharmacologia. 1964 Mar 11;5:301-5. doi: 10.1007/BF02341262.

Assessment of drug therapy in Parkinsonism.

Br Med J. 1963 Feb 16;1(5328):443-8. doi: 10.1136/bmj.1.5328.443.

引用本文的文献

The management of neuroleptic-induced CNS effects.

Can Fam Physician. 1981 Oct;27:1615-24.

Intestinal obstruction complicating orphenadrine treatment.

Br Med J. 1976 Jan 3;1(6000):21-2. doi: 10.1136/bmj.1.6000.21-a.